Emerging Trends to Reshape the Sexually Transmitted Infections (STIs) Market: Innovative Fluorescent Pcr Technology Advancements By Leading Companies In The Sexually Transmitted Infections (STIS) Market as a Key Influencer

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Sexually Transmitted Infections (STIs) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the recent past, the market size for sexually transmitted infections (STIs) has seen a considerable increase. This market is predicted to rise from a value of $63.69 billion in 2024 to an estimated value of $71.93 billion in 2025, with a compound annual growth rate (CAGR) of 12.9%. The market expansion during this historic period is largely due to a number of key factors such as changes in behavior, efforts towards education and awareness, accessibility to healthcare, and advancements in antibiotic development.

Sexually Transmitted Infections (STIs) Market Size Forecast: What's the Projected Valuation by 2029?
The market size for sexually transmitted infections (STIs) is projected to experience rapid expansion in the imminent years. It's estimated to escalate to $113.38 billion in 2029, with a compound annual growth rate (CAGR) of 12.0%. This growth during the projection period can be credited to new emerging STI strains, immunization efforts, telemedicine, and at-home screenings, alongside sexual health equality. The forecasted period is also expected to observe significant trends such as increasing antimicrobial resistance, pre-exposure prophylaxis (prep), STI self-care, and improved sexual education.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

What Are the Drivers Transforming the Sexually Transmitted Infections (STIs) Market?
The escalation of public health measures promoting awareness of sexually transmitted diseases is anticipated to fuel the expansion of the sexually transmitted infections (STIs) market in the future. Government-led initiatives are typically established to accomplish particular objectives and resolve specific issues. A variety of such initiatives concerning the prevention, management, and treatment of STIs are provided by the government. These include funding public education campaigns to increase STI knowledge, proposing vaccines to avoid certain STIs, and offering free or inexpensive screening and testing. For example, in April 2023, Springfield-Greene County Health, a public health department based in the US, launched a novel program, the Disease Intervention Specialist (DIS), in collaboration with the Missouri Department of Health and Senior Services (Missouri DHSS). The program targets the escalating spread of STIs in Greene County. The two specialists within the DIS program will primarily address cases of syphilis and HIV, liaising with those tested positive to provide them with treatment options and help them understand the nature of the infection. As a result, the escalating number of government initiatives is set to drive the growth in the STIs market. The increase in incidences of unprotected sexual practices is projected to bolster the expansion of the sexually transmitted infections (STIs) market. This trend refers to the growing tendency of individuals engaging in sexual activities without using protective measures like condoms, thereby facilitating the transmission of STIs. For example, according to data by the World Health Organization in August 2024, a UK-based intergovernmental body, the proportion of sexually active adolescents employing condoms during their most recent sexual encounters showed a decline in 2022. The number of boys using condoms dropped from 70% to 61%, while the figures for girls decreased from 63% to 57%. Hence, this trend of unprotected sexual practices contributes to the upward trend in the STIs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp

What Long-Term Trends Will Define the Future of the Sexually Transmitted Infections (STIs) Market?
Key players in the Sexually Transmitted Infections (STIs) market are leveraging fluorescent PCR (Polymerase Chain Reaction) technology to create advanced products and secure a competitive edge. Fluorescent PCR is a molecular biology technique used to identify and quantify specific DNA sequences in a biological sample. Take for example Jiangsu Bioperfectus Technologies Co. Ltd., a molecular diagnostic solutions firm based in China. In March 2023, the company launched two new PCR kits: the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These kits are comprehensive PCR solutions for the early detection of sexually transmitted diseases that affect many people. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit, a reagent employing the fluorescent PCR technology, can detect Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs, and urine samples. Similarly, the BioPerfectus Treponema Pallidum Real-Time PCR Kit is engineered to target and detect the Treponema pallidum nucleic acid in human serum and plasma.

Which Segments in the Sexually Transmitted Infections (STIs) Market Offer the Most Profit Potential?
The sexually transmitted infections (STIs) market covered in this report is segmented -

1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types
2) By Treatment: Antibiotics, Antiviral
3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea
4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis
5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13047&type=smp

Which Firms Dominate the Sexually Transmitted Infections (STIs) Market by Market Share and Revenue in 2025?
Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

Which Regions Offer the Highest Growth Potential in the Sexually Transmitted Infections (STIs) Market?
North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13047

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.